Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About

Axilone Group Acquires Majority Stake in Anewcos

Published January 21, 2022
Published January 21, 2022
Shutterstock

The Axilone Group has made a majority investment in Anewcos, a cosmetics formulation and filling company based in China.

WHO: Established in 2011, Anewcos is located in China's Suzhou, Jiangsu, province, and provides formulation, product development, and filling services to Chinese beauty brands. Anewcos specializes in skincare creams, loose powders, and foundation for color cosmetics.

Axilone is recognized for its expertise in plastic injection, aluminum stamping, decoration, and assembly processes. The group designs and produces premium packaging solutions for the skincare, makeup, and fragrance markets. Thanks to multi-material know-how, Axilone relies on a global network of directly owned industrial sites in France, Spain, and China.

WHY: This transaction enables the Axilone Group to accelerate its growth with brands in China and elsewhere, by offering turnkey solutions, and to diversify into product categories beyond lip makeup.

IN THEIR OWN WORDS: "Anewcos' expertise in formulation will also help us propose superior solutions when designing next generations of primary packaging," Axilone said in a statement.

DETAILS:

  • The Axilone Group has made a majority investment in Anewcos,
  • In 2018 CITIC Capital China Partners III, LP, a buyout fund managed by the private equity arm of CITIC Capital Holdings Limited, completed the acquisition of Axilone from Oaktree Capital Management, L.P.
×

2 Article(s) Remaining

Subscribe today for full access